查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684779

ECG 壓力測試市場機會、成長動力、產業趨勢分析和 2025 - 2034 年預測

ECG Stress Test Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球心電圖壓力測試市場規模達到 27 億美元，預計 2025 年至 2034 年期間的複合年成長率為 7.8%。這一成長是由全球心血管疾病發病率上升所推動的，而久坐的生活方式、不健康的飲食習慣和人口老化是導致這一現象的原因。由於心臟病仍然是死亡的主要原因，醫療保健提供者優先考慮早期診斷和預防性護理，從而增加了對心電圖壓力測試系統的需求。先進的診斷技術在改善患者治療效果、降低長期醫療成本和提高心臟評估效率方面發揮著至關重要的作用。由於定期心臟監測已成為疾病管理的重要組成部分，預防性醫療保健的轉變進一步加速了心電圖壓力測試的採用。

ECG 壓力測試市場 - IMG1

心電圖壓力測試系統的技術進步使得這些診斷工具更加準確、有效率且易於使用。人工智慧驅動的心電圖分析、無線監測以及與電子健康記錄 (EHR) 的整合正在改變心臟診斷，以實現更快、更精確的評估。此外，對遠距醫療和遠端監控解決方案的日益關注進一步擴大了市場的成長潛力，使得心電圖壓力測試更加方便和廣泛可用。醫療機構也正在投資先進的心電圖系統，以提供增強的資料分析和即時監控，從而可以早期發現心血管疾病。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 27億美元
預測值 57億美元
複合年成長率 7.8％

依產品類型，市場分為運動測試系統、壓力心電圖、壓力血壓監測器和脈搏血氧儀。運動測試系統預計將達到最高成長，預計複合年成長率為 8.1%，到 2034 年將達到 29 億美元。這些系統對於評估體力消耗下的心臟功能至關重要，對於檢測冠狀動脈疾病和心律不整不可或缺。人們對心血管篩檢重要性的認知不斷提高以及運動測試設備的進步正在推動醫療保健機構的廣泛採用。隨著心臟病發病率的上升，對高精度壓力測試解決方案的需求持續成長，醫療專業人士強調早期干預策略以降低風險。

根據最終用途，心電圖壓力測試市場分為醫院、診斷中心、門診手術中心和其他醫療機構。 2024 年，醫院佔據最大的市場佔有率，佔總收入的 46.3%。醫院配備了最先進的診斷工具和專門的心臟護理單元，仍然是心電圖壓力測試的首選。心臟病負擔日益加重，導致醫院就診人數激增，患者尋求專家的醫療評估和準確的心血管評估。醫院基礎設施的擴張以及心臟護理的進步進一步支持了市場的成長。

2024 年美國心電圖壓力測試市值為 8.646 億美元，預計到 2034 年複合年成長率為 7.1%。不良飲食習慣、肥胖和缺乏運動等生活方式相關的健康風險導致心血管疾病發生率高，是推動需求的關鍵因素。隨著人口老化導致心臟病患者數量不斷增加，醫療保健提供者正在投資尖端診斷技術，以促進早期發現和預防護理。人們對心血管健康的認知不斷提高，加上診斷設備技術的快速進步，預計將維持市場上升的趨勢。人工智慧、基於雲端的心電圖監測和增強資料分析的整合進一步加強了美國市場，使心電圖壓力測試更加高效，患者和醫療保健專業人員都可以更方便地進行心電圖壓力測試。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 心血管疾病盛行率上升
      • 提高人們對早期診斷心臟病益處的認知
      • 運動員接受測試次數激增
      • 與電子健康記錄 (EHR) 整合
    • 產業陷阱與挑戰
      • 心電圖壓力測試系統成本高
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未來市場趨勢
  • 價值鏈分析
  • 機器學習在心臟壓力測試解釋的應用

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：依產品類型，2021 年至 2034 年

  • 主要趨勢
  • 運動測試系統
  • 壓力心電圖
  • 壓力血壓監測儀
  • 脈搏血氧儀

第6章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 診斷中心
  • 門診手術中心
  • 其他最終用戶

第7章：市場估計與預測：按地區，2021 — 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章：公司簡介

  • Baxter
  • BD (Becton Dickinson)
  • BIOSENSORS INTERNATIONAL
  • Cardinal Health
  • COSMED
  • FUKUDA
  • GE (General Electric)
  • Halma
  • MGC DIAGNOSTICS
  • Neurosoft
  • NIHON KOHDEN
  • NONIN
  • OSI
  • PHILIPS
  • SCHILLER
簡介目錄
Product Code: 5705

The Global ECG Stress Test Market reached USD 2.7 billion in 2024 and is projected to grow at a CAGR of 7.8% between 2025 and 2034. This growth is driven by the rising incidence of cardiovascular diseases worldwide, fueled by sedentary lifestyles, unhealthy dietary habits, and an aging population. As heart disease remains a leading cause of mortality, healthcare providers are prioritizing early diagnosis and preventive care, increasing the demand for ECG stress test systems. Advanced diagnostic technologies are playing a crucial role in improving patient outcomes, reducing long-term healthcare costs, and enhancing the efficiency of cardiac assessments. The shift towards preventive healthcare has further accelerated the adoption of ECG stress tests, as regular cardiac monitoring becomes an essential component of disease management.

ECG Stress Test Market - IMG1

Technological advancements in ECG stress testing systems have made these diagnostic tools more accurate, efficient, and accessible. AI-driven ECG analysis, wireless monitoring, and integration with electronic health records (EHR) are transforming cardiac diagnostics, enabling faster and more precise assessments. Additionally, the increasing focus on telehealth and remote monitoring solutions has further expanded the market's growth potential, making ECG stress testing more convenient and widely available. Healthcare facilities are also investing in sophisticated ECG systems that offer enhanced data analytics and real-time monitoring, allowing for early detection of cardiovascular conditions.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$ 2.7 Billion
Forecast Value$ 5.7 Billion
CAGR7.8%

The market is segmented by product type into exercise testing systems, stress ECG, stress blood pressure monitors and pulse oximeters. Exercise testing systems are expected to witness the highest growth, with a projected CAGR of 8.1%, reaching USD 2.9 billion by 2034. These systems are vital in assessing heart function under physical exertion, making them indispensable for detecting coronary artery disease and irregular heart rhythms. Growing awareness about the importance of cardiovascular screening and advancements in exercise testing equipment are driving widespread adoption across healthcare settings. As the prevalence of heart disease rises, demand for high-precision stress testing solutions continues to grow, with medical professionals emphasizing early intervention strategies to mitigate risks.

By end use, the ECG stress test market is categorized into hospitals, diagnostic centers, ambulatory surgical centers, and other healthcare facilities. Hospitals held the largest market share in 2024, accounting for 46.3% of total revenue. Equipped with state-of-the-art diagnostic tools and specialized cardiac care units, hospitals remain the preferred choice for ECG stress testing. The increasing burden of heart disease has led to a surge in hospital visits, with patients seeking expert medical evaluations and accurate cardiovascular assessments. Hospital infrastructure expansion, along with advancements in cardiac care, is further supporting market growth.

The U.S. ECG stress test market was valued at USD 864.6 million in 2024 and is projected to grow at a CAGR of 7.1% through 2034. The high prevalence of cardiovascular diseases, driven by lifestyle-related health risks such as poor dietary habits, obesity, and physical inactivity, is a key factor fueling demand. With an aging population contributing to a rising number of heart conditions, healthcare providers are investing in cutting-edge diagnostic technologies to facilitate early detection and preventive care. Increasing awareness of cardiovascular health, coupled with rapid technological advancements in diagnostic equipment, is expected to sustain the market's upward trajectory. The integration of AI, cloud-based ECG monitoring, and enhanced data analytics is further strengthening the U.S. market, making ECG stress tests more efficient and accessible for both patients and healthcare professionals.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in prevalence of cardiovascular disorders
      • 3.2.1.2 Rising awareness for benefits associated with early diagnosis of heart diseases
      • 3.2.1.3 Surge in number of tests performed by sporting athletes
      • 3.2.1.4 Integration with electronic health records (EHRs)
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of ECG stress testing systems
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Value chain analysis
  • 3.11 Machine learning in cardiac stress test interpretation

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 — 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Exercise testing systems
  • 5.3 Stress ECG
  • 5.4 Stress blood pressure monitors
  • 5.5 Pulse oximeters

Chapter 6 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Diagnostic centers
  • 6.4 Ambulatory surgical centers
  • 6.5 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Baxter
  • 8.2 BD (Becton Dickinson)
  • 8.3 BIOSENSORS INTERNATIONAL
  • 8.4 Cardinal Health
  • 8.5 COSMED
  • 8.6 FUKUDA
  • 8.7 GE (General Electric)
  • 8.8 Halma
  • 8.9 MGC DIAGNOSTICS
  • 8.10 Neurosoft
  • 8.11 NIHON KOHDEN
  • 8.12 NONIN
  • 8.13 OSI
  • 8.14 PHILIPS
  • 8.15 SCHILLER